| Binding of a Fluorescent Lipid Amphiphile to Albumin and its Transfer to Lipid Bilayer Membranes Biophysical Journal, Volume 84, Issue 1, 1 January 2003, Pages 386-399 Magda S.C. Abreu, Luís M.B.B. Estronca, Maria João Moreno and Winchil L.C. Vaz Abstract Kinetics and thermodynamics of the binding of a fluorescent lipid amphiphile, Rhodamine Green™-tetradecylamide (RG-C), to bovine serum albumin were characterized in an equilibrium titration and by stopped-flow fluorimetry. The binding equilibrium of RG-C to albumin was then used to reduce its concentration in the aqueous phase to a value below its critical micelle concentration. Under these conditions, the only two species of RG-C in the system were the monomer in aqueous solution in equilibrium with the protein-bound species. After previous determination of the kinetic and thermodynamic parameters for association of RG-C with albumin, the kinetics of insertion of the amphiphile into and desorption off lipid bilayer membranes in different phases (solid, liquid-ordered, and liquid-disordered phases, presented as large unilamellar vesicles) were studied by stopped-flow fluorimetry at 30°C. Insertion and desorption rate constants for association of the RG-C monomer with the lipid bilayers were used to obtain lipid/water equilibrium partition coefficients for this fluorescent amphiphile. The direct measurement of these partition coefficients is shown to provide a new method for the indirect determination of the equilibrium partition coefficient of similar molecules between two defined lipid phases if they coexist in the same membrane. Abstract | Full Text | PDF (284 kb) |
| Diffusion Rate Limitations in Actin-Based Propulsion of Hard and Deformable Particles Biophysical Journal, Volume 91, Issue 4, 15 August 2006, Pages 1548-1563 Richard B. Dickinson and Daniel L. Purich Abstract The mechanism by which actin polymerization propels intracellular vesicles and invasive microorganisms remains an open question. Several recent quantitative studies have examined propulsion of biomimetic particles such as polystyrene microspheres, phospholipid vesicles, and oil droplets. In addition to allowing quantitative measurement of parameters such as the dependence of particle speed on its size, these systems have also revealed characteristic behaviors such a saltatory motion of hard particles and oscillatory deformation of soft particles. Such measurements and observations provide tests for proposed mechanisms of actin-based motility. In the actoclampin filament end-tracking motor model, particle-surface-bound filament end-tracking proteins are involved in load-insensitive processive insertion of actin subunits onto elongating filament plus-ends that are persistently tethered to the surface. In contrast, the tethered-ratchet model assumes working filaments are untethered and the free-ended filaments grow as thermal ratchets in a load-sensitive manner. This article presents a model for the diffusion and consumption of actin monomers during actin-based particle propulsion to predict the monomer concentration field around motile particles. The results suggest that the various behaviors of biomimetic particles, including dynamic saltatory motion of hard particles and oscillatory vesicle deformations, can be quantitatively and self-consistently explained by load-insensitive, diffusion-limited elongation of (+)-end-tethered actin filaments, consistent with predictions of the actoclampin filament-end tracking mechanism. Abstract | Full Text | PDF (459 kb) |
| Statistical Thermodynamics and Kinetics of DNA Multiplex Hybridization Reactions Biophysical Journal, Volume 91, Issue 11, 1 December 2006, Pages 4133-4153 M.T. Horne, D.J. Fish and A.S. Benight Abstract A general analytical description of the equilibrium and reaction kinetics of DNA multiplex hybridization has been developed. In this approach, multiplex hybridization is considered to be a competitive multichannel reaction process: a system wherein many species can react both specifically and nonspecifically with one another. General equations are presented that can consider equilibrium and kinetic models of multiplex hybridization systems comprised, in principle, of any number of targets and probes. Numerical solutions to these systems for both equilibrium and kinetic behaviors are provided. Practical examples demonstrate clear differences between results obtained from more common simplex methods, in which individual hybridization reactions are considered to occur in isolation; and multiplex hybridization, where desired and competitive cross-hybrid reactions between all possible pairs of strands are considered. In addition, sensitivities of the hybridization process of the perfect match duplex, to temperature, target concentration, and existence of sequence homology with other strands, are examined. This general approach also considers explicit sequence-dependent interactions between targets and probes involved in the reactions. Sequence-dependent stabilities of all perfect match and mismatch duplex complexes are explicitly considered and effects of relative stability of cross-hybrid complexes are also explored. Results reveal several interdependent factors that strongly influence DNA multiplex hybridization behavior. These include: relative concentrations of all probes and targets; relative thermodynamic stability of all perfect match and mismatch complexes; sensitivity to temperature, particularly for mismatches; and amount of sequence homology shared by the probe and target strands in the multiplex mix. Abstract | Full Text | PDF (532 kb) |
Copyright © 2007 The Biophysical Society. All rights reserved.
Biophysical Journal, Volume 93, Issue 11, 3828-3834, 1 December 2007
doi:10.1529/biophysj.107.110866
Biophysical Theory and Modeling
Department of Systems Biology, Harvard Medical School, Boston, Massachusetts
Address reprint requests to Jeremy Gunawardena, Dept. of Systems Biology, Harvard Medical School, 200 Longwood Ave., Boston, MA 02115. Tel.: 617-432-4839; Fax: 617-432-5012.Ever since the discovery of reversible protein phosphorylation 1, its importance as a key cellular regulatory mechanism has been increasingly appreciated 2. Disregulation of phosphorylation is implicated in several human diseases and both kinase and phosphatase inhibitors are important in the clinic 3,4. Prokaryotes predominantly use two-component histidine, aspartate phospho-transfer, whereas eukaryotes predominantly rely on serine, threonine, and tyrosine phosphorylation 5,6,7. Significantly, eukaryotes exhibit a striking difference in multisite modification 8,9. Bacterial and archaeal proteins are phosphorylated on at most a few sites under normal conditions 10,11, whereas eukaryotic proteins can be heavily phosphorylated 7: p53, which integrates the cell's DNA damage response, has 16 phosphorylation sites, targeted by several kinases and phosphatases 9.
A substrate molecule with n phosphorylation sites may be in one of 2n states and a population of molecules may contain a mixture of these different phospho-forms. Furthermore, the system of kinases, phosphatases, and substrate is maintained far from equilibrium in vivo by a steady supply of ATP. This is a recipe for complex emergent behavior but this has rarely been seen either in vivo or in vitro. In vivo studies are hampered by the need for single-cell resolution and the absence of real-time sensors for phosphorylation state. In vitro studies are normally done with either kinase or phosphatase. Recent exceptions to this have been the development of extract systems for phosphorylation studies 12 and the remarkable in vitro recapitulation of the cyanobacterial circadian oscillator 13, which manifests itself as an oscillation in multisite phosphorylation. These experimental studies hint at the complexity that is to be found with just three components: kinase, phosphatase, and substrate.
Despite their dynamical complexity, such systems can satisfy algebraic invariants at steady state. Invariants are algebraic expressions, which only involve measurable state variables, whose values are independent of the conditions under which the system is initiated, such as the total amounts of enzymes or substrate (Eq. (5)). We show here that these invariants provide a method for determining the mechanism of action of both kinases and phosphatases. This method has many advantages over current techniques, as summarized in the Discussion.
We consider a kinase E and phosphatase F acting on a substrate S with n phosphorylation sites. The enzymes are initially assumed to act distributively on S and to maintain a sequential order of phosphorylation. Distributivity means that at most one modification (addition or removal of phosphate) takes place in each encounter between substrate molecule and enzyme molecule 14. Accordingly, each phospho-form competes for both enzymes. Sequentiality means that sites are phosphorylated in a specific order and dephosphorylated in the reverse order, so that there are only n+1 phospho-forms, S0,⋯, Sn. Here, Si denotes the phospho-form with i sites phosphorylated in order. These assumptions give rise to a chain of reactions
![]() | (1) |
The enzymes are assumed to operate through a standard biochemical reaction scheme with reversible formation of an enzyme-substrate complex and irreversible formation of product:
![]() | (2) |
Here, X=E, 0≤i<n and the product is Si+1, or, X=F, 0<i≤n and the product is Si−1. Assuming mass-action kinetics, the reactions are labeled with their corresponding rate constants (“a” for association, “b” for breakup, and “c” for catalysis), with the subscript corresponding to the substrate of the reaction.
These assumptions are frequently used for multisite phosphorylation 14,15 although Eq. (2) is sometimes approximated by a Michaelis-Menten rate function 16,17,18. We make no approximations here. The relevance of our assumptions to current experimental understanding is reviewed in the Discussion.
Equations (1) give rise to a (3n+3)-dimensional dynamical system in which the state variables are the concentrations of the n+1 phospho-forms, S0,⋯Sn; the 2n enzyme-substrate complexes, ESi for 0≤i<n and FSj for 0<j≤n; and the two free enzymes, E and F. As modeled, the system is closed; ATP is assumed to be held constant, through a mechanism that is not explicitly modeled, and its effects absorbed into the rate constants. It follows, assuming a fixed reaction volume, that the total concentrations of substrate, [Stot], and enzymes, [Etot] and [Ftot], remain constant during any time evolution of the system. When started from some initial condition, the system would be expected to relax onto a stable steady state, in which the actions of the kinase and the phosphatase are in balance. Although it contains no explicit feedback, the system can exhibit multistability: there may be more than one steady state having the same total amounts of substrate and enzymes 17. Indeed, the maximal number of steady states increases with n (M. Thomson and J. Gunawardena, unpublished data).
Although this dynamical system is nonlinear, there is an analytic solution for it at steady state. We review this below but its main consequence is that, if [−] denotes concentration in any steady state,
![]() | (3) |
Here, using the notation introduced in Eq. (2), λi is the site-specific relative catalytic efficiency,
![]() | (4) |
is the site-specific Michaelis-Menten constant for X=E or X=F, 
Equation (3) has the following remarkable consequence. Dividing the formulas for i+1 by that for i, we see that
![]() | (5) |
The left-hand side of Eq. (5) depends only on the measurable state variables, S0,⋯, Sn, whereas the right-hand side depends only on the rate constants. Hence, in any experiment involving the same ingredients, no matter what amounts are used, no matter how the system is started and no matter what steady state is reached, the left-hand side must always have the same value. We refer to such quantities as invariants of the system. (There are further invariants of the form [Si+1][Sj]/([Si][Sj+1]) but these can be written in terms of those in Eq. (5).)
The main focus of this article is to ask what happens when Eq. (5) is not satisfied. One of the key assumptions made above is that both enzymes act distributively. An alternative hypothesis is that one or the other of the enzymes acts processively, allowing more than one modification to be made in each molecular encounter. Suppose given a kinase, phosphatase, substrate system with two phosphorylation sites, for which a variety of steady states are constructed having different total amounts of substrate and enzymes and different initial conditions and that, for each steady state, [S0][S2]/[S1]2 is plotted against [S2]/[S1]. We show below (see Fig. 1) that if both enzymes are distributive, the resulting graph is flat; if the kinase is distributive and the phosphatase is processive, the graph increases linearly; if the kinase is processive and the phosphatase distributive, the graph decreases hyperbolically; and if both enzymes are processive, the graph has a minimum, so that it first decreases and then increases. It follows that the mechanism of action of the enzymes can be determined by measurements carried out at steady state.
Extending this result to n>2, or to systems that are not sequential, is surprisingly difficult and requires different mathematical techniques. For instance, for a nonsequential system with two sites, which corresponds to the case of several interesting biological examples, the invariant is considerably more complicated than Eq. (5) (see Eq. (16)). We review these issues in the Discussion along with the challenges of experimentally verifying these predictions.
The results were obtained by algebraic calculation. Fig. 1 was generated in Mathematica (Wolfram Research, Champaign, IL).
Consider the enzymatic chain in Eq. (1) at steady state. Let ei be the net flux of substrate from Si to Si+1 due to enzyme E and let fi be the net flux of substrate in the same direction due to enzyme F. Since the system is at steady state, the net flux into Si+1 from the left, given by ei−fi, must equal the net flux out of Si+1 to the right, given by ei+1−fi+1. Hence ei−fi=ei+1−fi+1 for 0≤i<n. However, there is no net flux into S0 from the left, nor net flux out of Sn to the right. (Sequentiality is essential here.) It follows that ei=fi for 0≤i<n. In other words, at steady state, each individual loop in the chain is at steady state. This observation, which has been repeatedly made in different mathematical contexts, is well known to experts in biochemical kinetics 20.
The net fluxes are given by
and
It follows from Eq. (2) that at steady state,
so that
![]() | (6) |
![]() |
Consider the case n=2. We explain the difficulties with the general case in the Discussion. If E acts processively, then it only makes a difference to its phosphorylation of S0. We assume the following reaction scheme,
| (7) |
The different possibilities for product formation in Eq. (7) each have their own mass-action rate constants,
and
If
then the scheme reverts to that in Eq. (2) for a distributive kinase. We assume a symmetrical scheme to Eq. (7) for the processive dephosphorylation of S2, with catalytic rate constants
and
If
then the phosphatase reverts to being distributive.
We further assume that either
or
for if both are zero then there is no way to produce S1. The case of full processivity for both enzymes (that is, when exactly two modifications are done in each molecular encounter, so that
) can be easily handled, since it is equivalent to having only a single site. We will ignore this possibility here. It is in any case more reasonable to assume that full processivity means that the single modification rate is very small compared to the double modification rate, so that
for the kinase and
for the phosphatase and these conditions can be handled by the results below.
We will calculate [S0][S2]/[S1]2, assuming both kinase and phosphatase are processive, as described in Eq. (7). Because of the flux from S0 to S2 implied by this, the simple argument for the distributive case can no longer be used. However, balancing the net fluxes at S0 at steady state in a similar way, we see that
![]() | (8) |
and
are slightly modified so that![]() |
![]() |
![]() | (9) |
![]() | (10) |
Equations (9) are a pair of simultaneous linear equations for [S2]/[S1] and [S0][S1] in terms of the rate constants and [E]/[F]. To solve them, it is convenient to introduce relative catalytic efficiencies similar to λi in Eq. (4),
![]() | (11) |
λ0 as defined in Eq. (11) reduces to λ0 as defined in Eq. (4) for the distributive case and similarly for λ1 when the phosphatase is distributive. The parameters λ+ and λ− are specific to the processive case. Since we have assumed that either
or
it follows that λ+>λ−.Solving for [S2]/[S1] and [S0][S1] in Eqs. (9), we find that
![]() | (12) |
![]() | (13) |
Equation (13) provides a way to distinguish between the four possibilities for the mechanism of action of E and F. However, although the experimentalist can control [Etot], [Ftot], and [Stot] and measure [S0], [S1], and [S2], the quantities [E] and [F] are determined by the dynamics of the system and cannot readily be measured or controlled. The second formula in Eq. (12) shows that [E]/[F] is a linear function of [S2]/[S1] and the latter can be measured. To exploit this, it is helpful to further simplify the algebra. Let
![]() | (14) |
Note that 1−α=κρ/d. If the kinase is distributive then
λ−=0, and κ=0; if the phosphatase is distributive then
λ+=∞, and ρ=0; since λ+>λ−, 0<α≤1 and if either kinase or phosphatase is distributive then α=1; d reverts to the value that [S0][S2]/[S1]2 has when both enzymes are distributive. Let x=[S2]/[S1]. Substituting for [E]/[F] in terms of x in Eq. (13), we find that
![]() | (15) |
Note from the second equation in Eq. (12) that αx−κ>0. There are four cases to consider.
In this case κ=ρ=0 and α=1. Hence, [S0][S2]/[S1]2=d, in accordance with Eq. (5). It does not change with x.
In this case κ=0 and α=1. Hence, [S0][S2]/[S1]2=ρx+d, which increases linearly with x. When graphed, this gives a straight line whose intercept on the vertical axis is d, the value that [S0][S2]/[S1]2 would have if F were distributive with a catalytic rate of
The slope of the graph is
![]() |
the catalytic rate for producing S0 from S2. In particular, no matter how processive F is (that is, no matter how small
is), the slope of the graph cannot exceed the ratio of the catalytic efficiencies of E at sites 1 and 0. If this latter number can be estimated, then measurement of the slope gives an estimate of the degree of processivity of F,
In particular, full processivity of the phosphatase, where
can be detected.In this case, ρ=0 and α=1. Hence, [S0][S2]/[S1]2=κd/(x−κ)+d. When graphed, this gives a hyperbola, whose singularity occurs at
![]() |
the catalytic rate for producing S2 for S0. In particular, it can never exceed the ratio of the catalytic efficiencies of F at sites 1 and 2. If this number can be estimated, then measurement of the position of the singularity gives an estimate of the degree of processivity of the kinase,
In particular, full processivity, where
can be detected. The asymptote as
is d, the value that [S0][S2]/[S1]2 would have if E were distributive with a catalytic rate of 
In this case, the right-hand side of Eq. (15) defines a function whose graph first decreases as x increases away from x=κ/α but then increases as
It has a singularity at x=κ/α and a minimum at
![]() |
The ratio of the position of the minimum to the position of the singularity gives an estimate of α, which then allows κ to be recovered. The minimum value is
which allows d to also be estimated.
Provided a sufficiently broad range of [S2]/[S1] values can be obtained by varying the total concentrations and initial conditions then not only can the mechanisms of action of E and F be deduced but values of the relevant compound parameters in Eq. (14) can also be estimated, without the need for any fitting.
Fig. 1 shows the graphs of [S0][S2]/[S1]2 against [S2]/[S1] for four systems in which all nonzero catalytic constants are 1 and all Michaelis-Menten constants are 1 (units may be chosen arbitrarily provided they are consistent between the two sets of constants). When both enzymes are processive the parameter values in Eq. (15) are
![]() |
Fig. 1 shows how easily the different cases can be distinguished by qualitative comparison and how the parameters can be quickly estimated, as described above.
Experimental determination of distributivity or processivity has been based on time course experiments. If the rate of production of highly phosphorylated phospho-forms is unchanged as the concentration of unphosphorylated substrate is increased or if production of highly phosphorylated phospho-forms cannot be interrupted by a competitor, that provides evidence for a highly processive mechanism 21,22,23,24,25. Although these methods can detect processivity, additional experiments are usually required at either end of the processivity scale, when the system is distributive or fully processive 22.
The method introduced in this article has several advantages. 1), Only a single set of steady-state measurements is required, using both kinase and phosphatase. If only one of the enzymes is of interest, the other can be chosen arbitrarily. 2), It gives the mechanism of both kinase and phosphatase simultaneously. 3), Classification of the mechanisms is by qualitative distinctions in the shapes of graphs, as in Fig. 1. 4), It does not require careful control of initial conditions or concentrations, which may be chosen in any convenient way to generate a broad range of [S2]/[S1] values. 5), It does not require additional experiments at the distributive end of the processivity scale, irrespective of the mechanism of the other enzyme. 6), The degree of processivity of one of the enzymes can be quantitatively determined without the need for any fitting, provided that site-specific catalytic efficiencies of the other enzyme can be estimated. In this case, full processivity of the first enzyme can also be determined. 7), Once the site-specific catalytic efficiencies have been estimated for one standard kinase or phosphatase, they can be used in conjunction with any cognate phosphatase or kinase, respectively. 8), In all cases, the relevant compound parameters in Eq. (15) can be estimated without the need for any fitting.
The results of this article focus attention on two principles: first, the importance of studying multisite phosphorylation as a system, with both kinase and phosphatase present. Although this is always the case in vivo, in vitro studies, with the notable exception of recent work in extracts 12, have customarily focused on each enzyme individually. Second, there are polynomial invariants at steady state, which encode useful information about enzyme mechanisms. Further development of these ideas must confront both experimental and theoretical challenges.
The experimenter must deal with two issues. First, as mentioned, steady states need to be generated. Bringing kinase and phosphatase together creates a futile cycle, which churns ATP. The resulting buildup of ADP and inorganic phosphate can poison the reactions, effectively compromising the biochemical scheme in Eq. (2). A similar problem is experienced in high-throughput in vitro translation systems for which a remedy was found by using reaction chambers separated from a larger buffer volume by a dialysis membrane, thereby allowing dilution of reaction products 26. In our laboratory, we are adapting a commercial in vitro translation system for multisite phosphorylation studies, which we expect to give improved reproducibility of steady states.
Second, given a substrate with n sites, it is necessary to distinguish and quantify all 2n potential phospho-forms. Although antibodies are frequently used to detect phosphorylation, they can be ill-suited to distinguishing phosphorylation patterns. For instance, Erk2 (the p42 MAP kinase) is one of the most frequently studied phospho-proteins. It is doubly phosphorylated on threonine (T) and tyrosine (Y) in a three residue T-Y motif in its activation loop. Although commercial antibodies exist to the intermediate phospho-forms, (pT)-Y and T-(pY), we have found that they show unacceptable cross-reactivity on quantitative Western blots. (In contrast, antibodies against the maximally phosphorylated phospho-form, (pT)-(pY), and the unphosphorylated substrate, T-Y, are much more specific.) Mass spectrometry (MS) holds much promise for phospho-protein analysis 7,10,27. One problem with MS, as with other forms of protein separation such as isoelectric focusing, is that different phospho-forms may have the same mass/charge ratios. Moreover, since proteins must first be digested into peptides, even if the phospho-peptides can be distinguished, the phospho-proteins still have to be deconvoluted from the phospho-peptides. We believe that a combination of isoelectric focusing, followed by high-performance liquid chromatography and tandem MS, will be able to distinguish and quantify all 2n phospho-forms on a substrate with n sites, for low values of n. We are developing such a protocol in collaboration with Hanno Steen.
On the theoretical side, it turns out to be surprisingly awkward to extend the results of this article to n>2 or to nonsequential systems. The latter would be most useful initially, because, even for n=2, it brings important biological examples within the scope of our methods.
Of the two assumptions made in our analysis, degrees of processivity in posttranslational modification are well attested in the literature. Both distributive and processive enzymes are known and these properties can significantly impact cellular regulation 14,28,29. Phosphorylation of Erk2 by the MAP kinase kinase Mek is distributive 22,23, as is dephosphorylation of Erk2 by the phosphatase MKP3 30. The p38 MAP kinase also doubly phosphorylates the transcription factor ATF2 through a distributive mechanism 31. Phosphorylation of p130Cas on 15 sites by Src appears highly processive 24, as does phosphorylation of the alternative splicing factor ASF/SF2 on nine sites by serine-arginine protein-specific kinase SRPK1 25. Phosphorylation of the phosphate regulator Pho4 on five sites by the Cyclin-CDK complex Pho80-Pho85 is partially processive, with an average of 2.1 phosphorylations per molecular encounter 21.
The other assumption, of sequentiality, has been less well documented. This assumption is commonly made in theoretical studies of multisite phosphorylation 14,15,16,17,18,32 (a recent exception being Salazar and Höfer 33). Sequential kinases are certainly known. For instance, GSK3, in its mode of primed phosphorylation, phosphorylates SXXXS repeat motifs on several substrates in a strict C to N order 34. The receptor tyrosine kinase FGFR1 also auto-phosphorylates in a strict order 35. These examples suggest that cognate phosphatases may cooperate to maintain a sequential system of kinase, phosphatase, and substrate. However, no such phosphatase is currently known.
Nonsequential systems are more difficult to analyze because the calculations required are nonlinear. In broad terms, methods of algebraic geometry, rather than linear algebra, are needed. In joint work with Arjun Manrai, we have been able to show that a two-site system in which both kinase and phosphatase are distributive has the following invariant:
![]() | (16) |
The case n>2 presents similar difficulties. The steady-state equations corresponding to Eqs. (9) are no longer linear in the [Si+1]/[Si] and their reciprocals. Furthermore, with increasing numbers of sites, the nature of the processivity becomes more complicated. Is there a processivity bound, so that no more than k modifications are made in any encounter? If the system is nonsequential, can any pattern of modifications be made or does this depend on the pattern of modifications already made? Such questions can only be answered by detailed experiments on specific kinase, phosphatase, substrate systems. This is work in progress in our laboratory.
Multisite protein phosphorylation and dephosphorylation are key cellular regulatory mechanisms. We hope that the results of this article will encourage both theoreticians and experimentalists to further unravel their emergent complexity.
We thank the editor and two anonymous reviewers for their helpful comments and Hanno Steen and Arjun Manrai for permission to mention results from unpublished joint work.
1. (1997). Protein phosphorylation and cellular regulation, I. In Nobel Lectures, Physiology or Medicine 1991–1995. Ringertz, N., ed. (Singapore: World Scientific). PubMed
2. (2002). Evolution of protein kinase signalling from yeast to man. Trends Biochem. Sci. 27, 514–520. Abstract | Full Text | PDF (149 kb) | CrossRef | PubMed
3. (2005). Role of protein phosphorylation on serine/threonine and tyrosine in the virulence of bacterial pathogens. J. Mol. Microbiol. Biotechnol. 9, 198–213. CrossRef | PubMed
4. (2001). The role of reversible protein phosphorylation in health and disease. Eur. J. Biochem. 268, 5001–5010. CrossRef | PubMed
5. (2000). Two component signal transduction. Annu. Rev. Biochem. 69, 183–215. CrossRef | PubMed
6. (2003). Archaeal protein kinases and phosphatases: insights from genomics and biochemistry. Biochem. J. 370, 373–389. CrossRef | PubMed
7. (2002). Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol. 20, 261–268. Abstract | Full Text | PDF (124 kb) | CrossRef | PubMed
8. (2000). The regulation of protein function by multisite phosphorylation: a 25 year update. Trends Biochem. Sci. 25, 596–601. Abstract | Full Text | PDF (214 kb) | CrossRef | PubMed
9. (2002). Multisite phosphorylation provides sophisticated regulation of transcription factors. Trends Biochem. Sci. 27, 619–627. Abstract | Full Text | PDF (712 kb) | CrossRef | PubMed
10. (2007). The serine/threonine/tyrosine phosphoproteome of the model bacterium Bacillus subtilis. Mol. Cell. Proteomics 6, 697–707. PubMed
11. (2004). Highly phosphorylated bacterial proteins. Proteomics 4, 3068–3077. CrossRef | PubMed
12. (2007). Substrate competition as a source of ultrasensitivity in the inactivation of Wee1. Cell 128, 1133–1145. Abstract | Full Text | PDF (1394 kb) | CrossRef | PubMed
13. (2005). Reconstitution of circadian oscillation of cyanobacterial KaiC phosphorylation in vitro. Science 308, 414–415. CrossRef | PubMed
14. (1996). Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 93, 10078–10083. CrossRef | PubMed
15. (2000). Scaffold proteins may biphasically affect the levels of mitogen-activated protein kinase signaling and reduce its threshold properties. Proc. Natl. Acad. Sci. USA 97, 5818–5823. CrossRef | PubMed
16. (2003). Allosteric regulation of the transcription factor NFAT1 by multiple phosphorylation sites: a mathematical analysis. J. Mol. Biol. 327, 31–45. CrossRef | PubMed
17. (2004). Signalling switches and bistability arising from multisite phosphorylation in protein kinase cascades. J. Cell Biol. 164, 353–359. CrossRef | PubMed
18. (2006). Bistability from double phosphorylation in signal transduction. FEBS J. 273, 3915–3926. CrossRef | PubMed
19. Reference deleted in press..
20. (1985). Cooperativity Theory in Biochemistry: Steady-State and Equilibrium Systems. Springer Series in Molecular Biology. (NY: Springer-Verlag). PubMed
21. (2001). Multi-site phosphorylation of Pho4 by the cyclin-CDK Pho80-Pho85 is semi-processive with site preference. J. Mol. Biol. 306, 997–1010. CrossRef | PubMed
22. (1997). Mechanistic studies of the dual phosphorylation of mitogen-activated protein kinase. J. Biol. Chem. 272, 19008–19016. CrossRef | PubMed
23. (1997). The activating dual phosphorylation of MAPK by MEK is nonprocessive. Biochemistry 36, 5929–5933. PubMed
24. (2001). Processive phosphorylation of p130Cas by Src depends on SH3-polyproline interactions. J. Biol. Chem. 276, 28190–28196. CrossRef | PubMed
25. (2003). Processive phosphorylation of alternative splicing factor/splicing factor 2. Proc. Natl. Acad. Sci. USA 100, 12601–12606. CrossRef | PubMed
26. (1988). A continuous cell-free translation system capable of producing polypeptides in high yield. Science 242, 1162–1164. PubMed
27. (2005). Phosphorylation analysis by mass spectrometry: myths, facts, and the consequences for qualitative and quantitative measurements. Mol. Cell. Proteomics 5, 172–181. CrossRef | PubMed
28. (2006). The processivity of multiubiquitination by the APC determines the order of substrate degradation. Cell 124, 89–103. Abstract | Full Text | PDF (1111 kb) | CrossRef | PubMed
29. (1998). The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science 280, 895–898. CrossRef | PubMed
30. (2001). The mechanism of dephosphorylation of extracellular signal-regulated kinase 2 by mitogen-activated protein kinsae phosphatase 3. J. Biol. Chem. 276, 32382–32391. CrossRef | PubMed
31. (2001). The kinetic mechanism of the dual phosphorylation of the ATF2 transcription factor by p38 mitogen activated protein (MAP) kinase α. J. Biol. Chem. 278, 5676–5684. PubMed
32. (2005). Multisite protein phosphorylation makes a good threshold but can be a poor switch. Proc. Natl. Acad. Sci. USA 102, 14617–14622. CrossRef | PubMed
33. (2007). Versatile regulation of multisite protein phosphorylation by the order of phosphate processing and protein-protein interactions. FEBS J. 274, 1046–1060. CrossRef | PubMed
34. (2001). Regulation of GSK-3: a cellular multiprocessor. Cell 105, 821–824. Full Text | PDF (104 kb) | CrossRef | PubMed
35. (2006). Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction. Mol. Cell 21, 711–717. Abstract | Full Text | PDF (511 kb) | CrossRef | PubMed